-
1
-
-
67749118059
-
LRRK2 gene variation and its contribution to Parkinson disease
-
Paisan-Ruiz, C. (2009) LRRK2 gene variation and its contribution to Parkinson disease. Hum. Mutat. 30, 1153-1160
-
(2009)
Hum. Mutat
, vol.30
, pp. 1153-1160
-
-
Paisan-Ruiz, C.1
-
2
-
-
69149089036
-
Molecular pathogenesis of Parkinson disease: Insights from genetic studies
-
Gasser, T. (2009) Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev. Mol. Med. 11, e22
-
(2009)
Expert Rev. Mol. Med
, vol.11
-
-
Gasser, T.1
-
3
-
-
70549084415
-
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
-
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A. et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 41, 1303-1307
-
(2009)
Nat. Genet
, vol.41
, pp. 1303-1307
-
-
Satake, W.1
Nakabayashi, Y.2
Mizuta, I.3
Hirota, Y.4
Ito, C.5
Kubo, M.6
Kawaguchi, T.7
Tsunoda, T.8
Watanabe, M.9
Takeda, A.10
-
4
-
-
70549088602
-
Genome-wide association study reveals genetic risk underlying Parkinson's disease
-
Simon-Sanchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G. et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308-1312
-
(2009)
Nat. Genet
, vol.41
, pp. 1308-1312
-
-
Simon-Sanchez, J.1
Schulte, C.2
Bras, J.M.3
Sharma, M.4
Gibbs, J.R.5
Berg, D.6
Paisan-Ruiz, C.7
Lichtner, P.8
Scholz, S.W.9
Hernandez, D.G.10
-
5
-
-
84859339977
-
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database
-
Lill, C. M., Roehr, J. T., McQueen, M. B., Kavvoura, F. K., Bagade, S., Schjeide, B. M., Schjeide, L. M., Meissner, E., Zauft, U., Allen, N. C. et al. (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet. 8, e1002548
-
(2012)
PLoS Genet
, vol.8
-
-
Lill, C.M.1
Roehr, J.T.2
McQueen, M.B.3
Kavvoura, F.K.4
Bagade, S.5
Schjeide, B.M.6
Schjeide, L.M.7
Meissner, E.8
Zauft, U.9
Allen, N.C.10
-
6
-
-
80052967403
-
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: A case-control study
-
Ross, O. A., Soto-Ortolaza, A. I., Heckman, M. G., Aasly, J. O., Abahuni, N., Annesi, G., Bacon, J. A., Bardien, S., Bozi, M., Brice, A. et al. (2011) Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol. 10, 898-908
-
(2011)
Lancet Neurol
, vol.10
, pp. 898-908
-
-
Ross, O.A.1
Soto-Ortolaza, A.I.2
Heckman, M.G.3
Aasly, J.O.4
Abahuni, N.5
Annesi, G.6
Bacon, J.A.7
Bardien, S.8
Bozi, M.9
Brice, A.10
-
7
-
-
33646151866
-
LRRK2 in Parkinson's disease: Protein domains and functional insights
-
Mata, I. F., Wedemeyer, W. J., Farrer, M. J., Taylor, J. P. and Gallo, K. A. (2006) LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci. 29, 286-293
-
(2006)
Trends Neurosci
, vol.29
, pp. 286-293
-
-
Mata, I.F.1
Wedemeyer, W.J.2
Farrer, M.J.3
Taylor, J.P.4
Gallo, K.A.5
-
8
-
-
80054787664
-
What genetics tells us about the causes and mechanisms of Parkinson's disease
-
Corti, O., Lesage, S. and Brice, A. (2011) What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol. Rev. 91, 1161-1218
-
(2011)
Physiol. Rev
, vol.91
, pp. 1161-1218
-
-
Corti, O.1
Lesage, S.2
Brice, A.3
-
9
-
-
28044460070
-
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
-
DOI 10.1073/pnas.0507360102
-
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L. and Dawson, T. M. (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. U. S. A. 102, 16842-16847 (Pubitemid 41688864)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.46
, pp. 16842-16847
-
-
West, A.B.1
Moore, D.J.2
Biskup, S.3
Bugayenko, A.4
Smith, W.W.5
Ross, C.A.6
Dawson, V.L.7
Dawson, T.M.8
-
10
-
-
80052828693
-
Kinases as targets for Parkinson's disease; from genetics to therapy
-
Vancraenenbroeck, R., Lobbestael, E., De Maeyer, M., Baekelandt, V. and Taymans, J. M. (2011) Kinases as targets for Parkinson's disease; from genetics to therapy. CNS Neurol. Disord.: Drug Targets 10, 724-740
-
(2011)
CNS Neurol. Disord.: Drug Targets
, vol.10
, pp. 724-740
-
-
Vancraenenbroeck, R.1
Lobbestael, E.2
De Maeyer, M.3
Baekelandt, V.4
Taymans, J.M.5
-
11
-
-
77953395313
-
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: Three questions
-
art:, doi:10.1042/AN20090007
-
Greggio, E. and Cookson, M. R. (2009) Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN NEURO 1, art: e00002, doi:10.1042/AN20090007
-
(2009)
ASN NEURO
, vol.1
-
-
Greggio, E.1
Cookson, M.R.2
-
12
-
-
33846562487
-
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
-
DOI 10.1093/hmg/ddl471
-
West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K. L., Dawson, V. L. and Dawson, T. M. (2007) Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16, 223-232 (Pubitemid 46179004)
-
(2007)
Human Molecular Genetics
, vol.16
, Issue.2
, pp. 223-232
-
-
West, A.B.1
Moore, D.J.2
Choi, C.3
Andrabi, S.A.4
Li, X.5
Dikeman, D.6
Biskup, S.7
Zhang, Z.8
Lim, K.-L.9
Dawson, V.L.10
Dawson, T.M.11
-
13
-
-
84860389765
-
Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities
-
Webber, P. J., Smith, A. D., Sen, S., Renfrow, M. B., Mobley, J. A. and West, A. B. (2011) Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities. J. Mol. Biol. 412, 94-110
-
(2011)
J. Mol. Biol
, vol.412
, pp. 94-110
-
-
Webber, P.J.1
Smith, A.D.2
Sen, S.3
Renfrow, M.B.4
Mobley, J.A.5
West, A.B.6
-
14
-
-
83855160771
-
Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibition
-
Doggett, E. A., Zhao, J., Mork, C. N., Hu, D. and Nichols, R. J. (2011) Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibition. J. Neurochem. 120, 37-45
-
(2011)
J. Neurochem
, vol.120
, pp. 37-45
-
-
Doggett, E.A.1
Zhao, J.2
Mork, C.N.3
Hu, D.4
Nichols, R.J.5
-
15
-
-
77956655427
-
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-13-3 binding and altered cytoplasmic localization
-
Dzamko, N., Deak, M., Hentati, F., Reith, A. D., Prescott, A. R., Alessi, D. R. and Nichols, R. J. (2010) Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-13-3 binding and altered cytoplasmic localization. Biochem. J. 430, 405-413
-
(2010)
Biochem. J
, vol.430
, pp. 405-413
-
-
Dzamko, N.1
Deak, M.2
Hentati, F.3
Reith, A.D.4
Prescott, A.R.5
Alessi, D.R.6
Nichols, R.J.7
-
16
-
-
79952302007
-
Phosphorylation-dependent 14-13-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease
-
Li, X., Wang, Q. J., Pan, N., Lee, S., Zhao, Y., Chait, B. T. and Yue, Z. (2011) Phosphorylation-dependent 14-13-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease. PLoS ONE 6, e17153
-
(2011)
PLoS ONE
, vol.6
-
-
Li, X.1
Wang, Q.J.2
Pan, N.3
Lee, S.4
Zhao, Y.5
Chait, B.T.6
Yue, Z.7
-
17
-
-
77956674229
-
14-13-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
-
Nichols, R. J., Dzamko, N., Morrice, N. A., Campbell, D. G., Deak, M., Ordureau, A., Macartney, T., Tong, Y., Shen, J., Prescott, A. R. and Alessi, D. R. (2010) 14-13-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization. Biochem. J. 430, 393-404
-
(2010)
Biochem. J
, vol.430
, pp. 393-404
-
-
Nichols, R.J.1
Dzamko, N.2
Morrice, N.A.3
Campbell, D.G.4
Deak, M.5
Ordureau, A.6
Macartney, T.7
Tong, Y.8
Shen, J.9
Prescott, A.R.10
Alessi, D.R.11
-
18
-
-
84866704591
-
Phosphorylation of LRRK2: From kinase to substrate
-
Lobbestael, E., Baekelandt, V. and Taymans, J. M. (2012) Phosphorylation of LRRK2: from kinase to substrate. Biochem. Soc. Trans. 40, 1102-1110
-
(2012)
Biochem. Soc. Trans
, vol.40
, pp. 1102-1110
-
-
Lobbestael, E.1
Baekelandt, V.2
Taymans, J.M.3
-
19
-
-
77950631558
-
Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2
-
Gloeckner, C. J., Boldt, K., von Zweydorf, F., Helm, S., Wiesent, L., Sarioglu, H. and Ueffing, M. (2010) Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2. J. Proteome. Res. 9, 1738-1745
-
(2010)
J. Proteome. Res
, vol.9
, pp. 1738-1745
-
-
Gloeckner, C.J.1
Boldt, K.2
Von Zweydorf, F.3
Helm, S.4
Wiesent, L.5
Sarioglu, H.6
Ueffing, M.7
-
20
-
-
83855160771
-
Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibition
-
Doggett, E. A., Zhao, J., Mork, C. N., Hu, D. and Nichols, R. J. (2012) Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibition. J. Neurochem. 120, 37-45
-
(2012)
J. Neurochem
, vol.120
, pp. 37-45
-
-
Doggett, E.A.1
Zhao, J.2
Mork, C.N.3
Hu, D.4
Nichols, R.J.5
-
21
-
-
84862497413
-
The IκB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during toll-like receptor signaling
-
Dzamko, N., Inesta-Vaquera, F., Zhang, J., Xie, C., Cai, H., Arthur, S., Tan, L., Choi, H., Gray, N., Cohen, P. et al. (2012) The IκB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during toll-like receptor signaling. PLoS ONE 7, e39132
-
(2012)
PLoS ONE
, vol.7
-
-
Dzamko, N.1
Inesta-Vaquera, F.2
Zhang, J.3
Xie, C.4
Cai, H.5
Arthur, S.6
Tan, L.7
Choi, H.8
Gray, N.9
Cohen, P.10
-
22
-
-
84865515027
-
Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation
-
Hermanson, S. B., Carlson, C. B., Riddle, S. M., Zhao, J., Vogel, K. W., Nichols, R. J. and Bi, K. (2012) Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation. PLoS ONE 7, e43580
-
(2012)
PLoS ONE
, vol.7
-
-
Hermanson, S.B.1
Carlson, C.B.2
Riddle, S.M.3
Zhao, J.4
Vogel, K.W.5
Nichols, R.J.6
Bi, K.7
-
23
-
-
33846818834
-
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
-
DOI 10.1021/bi061960m
-
Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T. and Iwatsubo, T. (2007) GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease. Biochemistry 46, 1380-1388 (Pubitemid 46208485)
-
(2007)
Biochemistry
, vol.46
, Issue.5
, pp. 1380-1388
-
-
Ito, G.1
Okai, T.2
Fujino, G.3
Takeda, K.4
Ichijo, H.5
Katada, T.6
Iwatsubo, T.7
-
24
-
-
79952918505
-
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
-
Deng, X., Dzamko, N., Prescott, A., Davies, P., Liu, Q., Yang, Q., Lee, J. D., Patricelli, M. P., Nomanbhoy, T. K., Alessi, D. R. and Gray, N. S. (2011) Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2. Nat. Chem. Biol. 7, 203-205
-
(2011)
Nat. Chem. Biol
, vol.7
, pp. 203-205
-
-
Deng, X.1
Dzamko, N.2
Prescott, A.3
Davies, P.4
Liu, Q.5
Yang, Q.6
Lee, J.D.7
Patricelli, M.P.8
Nomanbhoy, T.K.9
Alessi, D.R.10
Gray, N.S.11
-
25
-
-
70349991886
-
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model
-
Alegre-Abarrategui, J., Christian, H., Lufino, M. M., Mutihac, R., Venda, L. L., Ansorge, O. and Wade-Martins, R. (2009) LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum. Mol. Genet. 18, 4022-4034
-
(2009)
Hum. Mol. Genet
, vol.18
, pp. 4022-4034
-
-
Alegre-Abarrategui, J.1
Christian, H.2
Lufino, M.M.3
Mutihac, R.4
Venda, L.L.5
Ansorge, O.6
Wade-Martins, R.7
-
26
-
-
33746267531
-
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
-
DOI 10.1016/j.nbd.2006.04.001, PII S0969996106000714
-
Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J. et al. (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol. Dis. 23, 329-341 (Pubitemid 44097032)
-
(2006)
Neurobiology of Disease
, vol.23
, Issue.2
, pp. 329-341
-
-
Greggio, E.1
Jain, S.2
Kingsbury, A.3
Bandopadhyay, R.4
Lewis, P.5
Kaganovich, A.6
Van Der Brug, M.P.7
Beilina, A.8
Blackinton, J.9
Thomas, K.J.10
Ahmad, R.11
Miller, D.W.12
Kesavapany, S.13
Singleton, A.14
Lees, A.15
Harvey, R.J.16
Harvey, K.17
Cookson, M.R.18
-
27
-
-
84863012282
-
LRRK2 Parkinson disease mutations enhance its microtubule association
-
Kett, L. R., Boassa, D., Ho, C. C., Rideout, H. J., Hu, J., Terada, M., Ellisman, M. and Dauer, W. T. (2011) LRRK2 Parkinson disease mutations enhance its microtubule association. Hum. Mol. Genet. 21, 890-899
-
(2011)
Hum. Mol. Genet
, vol.21
, pp. 890-899
-
-
Kett, L.R.1
Boassa, D.2
Ho, C.C.3
Rideout, H.J.4
Hu, J.5
Terada, M.6
Ellisman, M.7
Dauer, W.T.8
-
28
-
-
27644457706
-
Upscaling of lentiviral vector production by tangential flow filtration
-
DOI 10.1002/jgm.778
-
Geraerts, M., Michiels, M., Baekelandt, V., Debyser, Z. and Gijsbers, R. (2005) Upscaling of lentiviral vector production by tangential flow filtration. J. Gene Med. 7, 1299-1310 (Pubitemid 41555436)
-
(2005)
Journal of Gene Medicine
, vol.7
, Issue.10
, pp. 1299-1310
-
-
Geraerts, M.1
Micheils, M.2
Baekelandt, V.3
Debyser, Z.4
Gijsbers, R.5
-
29
-
-
33750295885
-
Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors
-
DOI 10.1016/j.jviromet.2006.07.024, PII S0166093406002771
-
Reed, S. E., Staley, E. M., Mayginnes, J. P., Pintel, D. J. and Tullis, G. E. (2006) Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors. J. Virol. Methods 138, 85-98 (Pubitemid 44633451)
-
(2006)
Journal of Virological Methods
, vol.138
, Issue.1-2
, pp. 85-98
-
-
Reed, S.E.1
Staley, E.M.2
Mayginnes, J.P.3
Pintel, D.J.4
Tullis, G.E.5
-
30
-
-
80051611506
-
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding
-
Taymans, J. M., Vancraenenbroeck, R., Ollikainen, P., Beilina, A., Lobbestael, E., De Maeyer, M., Baekelandt, V. and Cookson, M. R. (2011) LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding. PLoS ONE 6, e23207
-
(2011)
PLoS ONE
, vol.6
-
-
Taymans, J.M.1
Vancraenenbroeck, R.2
Ollikainen, P.3
Beilina, A.4
Lobbestael, E.5
De Maeyer, M.6
Baekelandt, V.7
Cookson, M.R.8
-
31
-
-
77953578193
-
Proximity ligation assays: A recent addition to the proteomics toolbox
-
Weibrecht, I., Leuchowius, K. J., Clausson, C. M., Conze, T., Jarvius, M., Howell, W. M., Kamali-Moghaddam, M. and Soderberg, O. (2010) Proximity ligation assays: a recent addition to the proteomics toolbox. Expert Rev. Proteomics 7, 401-409
-
(2010)
Expert Rev. Proteomics
, vol.7
, pp. 401-409
-
-
Weibrecht, I.1
Leuchowius, K.J.2
Clausson, C.M.3
Conze, T.4
Jarvius, M.5
Howell, W.M.6
Kamali-Moghaddam, M.7
Soderberg, O.8
-
32
-
-
84864743687
-
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss of function mutation
-
Rudenko, I. N., Kaganovich, A., Hauser, D. N., Beylina, A., Chia, R., Ding, J., Maric, D., Jaffe, H. and Cookson, M. R. (2012) The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss of function mutation. Biochem. J. 446, 99-111
-
(2012)
Biochem. J
, vol.446
, pp. 99-111
-
-
Rudenko, I.N.1
Kaganovich, A.2
Hauser, D.N.3
Beylina, A.4
Chia, R.5
Ding, J.6
Maric, D.7
Jaffe, H.8
Cookson, M.R.9
-
33
-
-
0024517280
-
Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity
-
DOI 10.1016/0006-291X(89)92189-X
-
Ishihara, H., Martin, B. L., Brautigan, D. L., Karaki, H., Ozaki, H., Kato, Y., Fusetani, N., Watabe, S., Hashimoto, K., Uemura, D. et al. (1989) Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem. Biophys. Res. Commun. 159, 871-877 (Pubitemid 19101063)
-
(1989)
Biochemical and Biophysical Research Communications
, vol.159
, Issue.3
, pp. 871-877
-
-
Ishihara, H.1
Martin, B.L.2
Brautigan, D.L.3
Karaki, H.4
Ozaki, H.5
Kato, Y.6
Fusetani, N.7
Watabe, S.8
Hashimoto, K.9
Uemura, D.10
Hartshorne, D.J.11
-
34
-
-
35348998391
-
Structural basis for regulation of protein phosphatase 1 by inhibitor-2
-
DOI 10.1074/jbc.M703472200
-
Hurley, T. D., Yang, J., Zhang, L., Goodwin, K. D., Zou, Q., Cortese, M., Dunker, A. K. and De Paoli-Roach, A. A. (2007) Structural basis for regulation of protein phosphatase 1 by inhibitor-2. J. Biol. Chem. 282, 28874-28883 (Pubitemid 47606030)
-
(2007)
Journal of Biological Chemistry
, vol.282
, Issue.39
, pp. 28874-28883
-
-
Hurley, T.D.1
Yang, J.2
Zhang, L.3
Goodwin, K.D.4
Zou, Q.5
Cortese, M.6
Dunker, A.K.7
DePaoli-Roach, A.A.8
-
35
-
-
0033553546
-
Molecular determinants of nuclear protein phosphatase-1 regulation by NIPP-1
-
Beullens, M., Van Eynde, A., Vulsteke, V., Connor, J., Shenolikar, S., Stalmans, W. and Bollen, M. (1999) Molecular determinants of nuclear protein phosphatase-1 regulation by NIPP-1. J. Biol. Chem. 274, 14053-14061
-
(1999)
J. Biol. Chem
, vol.274
, pp. 14053-14061
-
-
Beullens, M.1
Van Eynde, A.2
Vulsteke, V.3
Connor, J.4
Shenolikar, S.5
Stalmans, W.6
Bollen, M.7
-
36
-
-
78650685500
-
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
-
Daniëls, V., Vancraenenbroeck, R., Law, B. M., Greggio, E., Lobbestael, E., Gao, F., De Maeyer, M., Cookson, M. R., Harvey, K., Baekelandt, V. and Taymans, J. M. (2011) Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant. J. Neurochem. 116, 304-315
-
(2011)
J. Neurochem
, vol.116
, pp. 304-315
-
-
Daniëls, V.1
Vancraenenbroeck, R.2
Law, B.M.3
Greggio, E.4
Lobbestael, E.5
Gao, F.6
De Maeyer, M.7
Cookson, M.R.8
Harvey, K.9
Baekelandt, V.10
Taymans, J.M.11
-
37
-
-
70349929185
-
Homoand heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment
-
Klein, C. L., Rovelli, G., Springer, W., Schall, C., Gasser, T. and Kahle, P. J. (2009) Homoand heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment. J. Neurochem. 111, 703-715
-
(2009)
J. Neurochem
, vol.111
, pp. 703-715
-
-
Klein, C.L.1
Rovelli, G.2
Springer, W.3
Schall, C.4
Gasser, T.5
Kahle, P.J.6
-
38
-
-
80054933395
-
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
-
Liu, Z., Lee, J., Krummey, S., Lu, W., Cai, H. and Lenardo, M. J. (2011) The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat. Immunol. 12, 1063-1070
-
(2011)
Nat. Immunol
, vol.12
, pp. 1063-1070
-
-
Liu, Z.1
Lee, J.2
Krummey, S.3
Lu, W.4
Cai, H.5
Lenardo, M.J.6
-
39
-
-
41549144503
-
The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2
-
DOI 10.1523/JNEUROSCI.0185-08.2008
-
Wang, L., Xie, C., Greggio, E., Parisiadou, L., Shim, H., Sun, L., Chandran, J., Lin, X., Lai, C., Yang, W. J. et al. (2008) The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. J. Neurosci. 28, 3384-3391 (Pubitemid 351469333)
-
(2008)
Journal of Neuroscience
, vol.28
, Issue.13
, pp. 3384-3391
-
-
Wang, L.1
Xie, C.2
Greggio, E.3
Parisiadou, L.4
Shim, H.5
Sun, L.6
Chandran, J.7
Lin, X.8
Lai, C.9
Yang, W.-J.10
Moore, D.J.11
Dawson, T.M.12
Dawson, V.L.13
Chiosis, G.14
Cookson, M.R.15
Cai, H.16
-
40
-
-
70350340056
-
Serine/threonine phosphatases: Mechanism through structure
-
Shi, Y. (2009) Serine/threonine phosphatases: mechanism through structure. Cell 139, 468-484
-
(2009)
Cell
, vol.139
, pp. 468-484
-
-
Shi, Y.1
-
41
-
-
77955279255
-
The extended PP1 toolkit: Designed to create specificity
-
Bollen, M., Peti, W., Ragusa, M. J. and Beullens, M. (2010) The extended PP1 toolkit: designed to create specificity. Trends Biochem. Sci. 35, 450-458
-
(2010)
Trends Biochem. Sci
, vol.35
, pp. 450-458
-
-
Bollen, M.1
Peti, W.2
Ragusa, M.J.3
Beullens, M.4
-
42
-
-
0346728803
-
Functional Diversity of Protein Phosphatase-1, a Cellular Economizer and Reset Button
-
DOI 10.1152/physrev.00013.2003
-
Ceulemans, H. and Bollen, M. (2004) Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84, 1-39 (Pubitemid 38049874)
-
(2004)
Physiological Reviews
, vol.84
, Issue.1
, pp. 1-39
-
-
Ceulemans, H.1
Bollen, M.2
-
43
-
-
2542435855
-
The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity
-
DOI 10.1016/j.febslet.2004.03.121, PII S001457930400506X
-
Munton, R. P., Vizi, S. and Mansuy, I. M. (2004) The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity. FEBS Lett. 567, 121-128 (Pubitemid 38686434)
-
(2004)
FEBS Letters
, vol.567
, Issue.1
, pp. 121-128
-
-
Munton, R.P.1
Vizi, S.2
Mansuy, I.M.3
-
44
-
-
33645790701
-
LRRK2 expression linked to dopamine-innervated areas
-
Galter, D., Westerlund, M., Carmine, A., Lindqvist, E., Sydow, O. and Olson, L. (2006) LRRK2 expression linked to dopamine-innervated areas. Ann. Neurol. 59, 714-719
-
(2006)
Ann. Neurol
, vol.59
, pp. 714-719
-
-
Galter, D.1
Westerlund, M.2
Carmine, A.3
Lindqvist, E.4
Sydow, O.5
Olson, L.6
-
45
-
-
33745917404
-
Distribution of PINK1 and LRRK2 in rat and mouse brain
-
DOI 10.1111/j.1471-4159.2006.03919.x
-
Taymans, J. M., Van den Haute, C. and Baekelandt, V. (2006) Distribution of PINK1 and LRRK2 in rat and mouse brain. J. Neurochem. 98, 951-961 (Pubitemid 44051294)
-
(2006)
Journal of Neurochemistry
, vol.98
, Issue.3
, pp. 951-961
-
-
Taymans, J.-M.1
Van Den Haute, C.2
Baekelandt, V.3
-
46
-
-
0029050576
-
Differential expression of protein phosphatase 1 isoforms in mammalian brain
-
da Cruz e Silva, E. F., Fox, C. A., Ouimet, C. C., Gustafson, E., Watson, S. J. and Greengard, P. (1995) Differential expression of protein phosphatase 1 isoforms in mammalian brain. J. Neurosci. 15, 3375-3389
-
(1995)
J. Neurosci
, vol.15
, pp. 3375-3389
-
-
Da Cruz E Silva, E.F.1
Fox, C.A.2
Ouimet, C.C.3
Gustafson, E.4
Watson, S.J.5
Greengard, P.6
-
47
-
-
66849115406
-
Targeting protein serine/threonine phosphatases for drug development
-
McConnell, J. L. and Wadzinski, B. E. (2009) Targeting protein serine/threonine phosphatases for drug development. Mol. Pharmacol. 75, 1249-1261
-
(2009)
Mol. Pharmacol
, vol.75
, pp. 1249-1261
-
-
McConnell, J.L.1
Wadzinski, B.E.2
|